BR9506147A - Novos derivados de eritromicina seu processo de preparação e sua aplicação como medicamentos - Google Patents

Novos derivados de eritromicina seu processo de preparação e sua aplicação como medicamentos

Info

Publication number
BR9506147A
BR9506147A BR9506147A BR9506147A BR9506147A BR 9506147 A BR9506147 A BR 9506147A BR 9506147 A BR9506147 A BR 9506147A BR 9506147 A BR9506147 A BR 9506147A BR 9506147 A BR9506147 A BR 9506147A
Authority
BR
Brazil
Prior art keywords
drugs
application
preparation process
erythromycin derivatives
new erythromycin
Prior art date
Application number
BR9506147A
Other languages
English (en)
Portuguese (pt)
Inventor
Constantin Agouridas
Yannick Benedetti
Jean-Francois Chantot
Alexis Denis
Martret Odile Le
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of BR9506147A publication Critical patent/BR9506147A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR9506147A 1994-04-08 1995-04-06 Novos derivados de eritromicina seu processo de preparação e sua aplicação como medicamentos BR9506147A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9404154A FR2718450B1 (fr) 1994-04-08 1994-04-08 Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
PCT/FR1995/000441 WO1995027720A1 (fr) 1994-04-08 1995-04-06 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
BR9506147A true BR9506147A (pt) 1996-04-16

Family

ID=9461886

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9506147A BR9506147A (pt) 1994-04-08 1995-04-06 Novos derivados de eritromicina seu processo de preparação e sua aplicação como medicamentos

Country Status (49)

Country Link
US (2) US5656607A (cg-RX-API-DMAC10.html)
EP (1) EP0676409B1 (cg-RX-API-DMAC10.html)
JP (1) JP3000023B2 (cg-RX-API-DMAC10.html)
KR (1) KR100317148B1 (cg-RX-API-DMAC10.html)
CN (1) CN1059445C (cg-RX-API-DMAC10.html)
AP (1) AP587A (cg-RX-API-DMAC10.html)
AT (1) ATE234853T1 (cg-RX-API-DMAC10.html)
AU (1) AU684939B2 (cg-RX-API-DMAC10.html)
BG (1) BG61916B1 (cg-RX-API-DMAC10.html)
BR (1) BR9506147A (cg-RX-API-DMAC10.html)
CA (1) CA2164638C (cg-RX-API-DMAC10.html)
CO (1) CO4370097A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ296005B6 (cg-RX-API-DMAC10.html)
DE (1) DE69529934T2 (cg-RX-API-DMAC10.html)
DK (1) DK0676409T3 (cg-RX-API-DMAC10.html)
DZ (1) DZ1869A1 (cg-RX-API-DMAC10.html)
EE (1) EE04498B1 (cg-RX-API-DMAC10.html)
ES (1) ES2189820T3 (cg-RX-API-DMAC10.html)
FI (1) FI111264B (cg-RX-API-DMAC10.html)
FR (1) FR2718450B1 (cg-RX-API-DMAC10.html)
GB (1) GB2288174A (cg-RX-API-DMAC10.html)
GE (1) GEP19991836B (cg-RX-API-DMAC10.html)
HR (1) HRP950217B1 (cg-RX-API-DMAC10.html)
HU (1) HU215396B (cg-RX-API-DMAC10.html)
IL (1) IL112954A (cg-RX-API-DMAC10.html)
IS (1) IS1865B (cg-RX-API-DMAC10.html)
JO (1) JO1850B1 (cg-RX-API-DMAC10.html)
LV (1) LV11182B (cg-RX-API-DMAC10.html)
MA (1) MA23501A1 (cg-RX-API-DMAC10.html)
MD (1) MD663G2 (cg-RX-API-DMAC10.html)
MY (1) MY114672A (cg-RX-API-DMAC10.html)
NO (1) NO308361B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ284498A (cg-RX-API-DMAC10.html)
OA (1) OA10200A (cg-RX-API-DMAC10.html)
PE (1) PE2896A1 (cg-RX-API-DMAC10.html)
PL (1) PL180837B1 (cg-RX-API-DMAC10.html)
PT (1) PT676409E (cg-RX-API-DMAC10.html)
RO (1) RO115634B1 (cg-RX-API-DMAC10.html)
RU (1) RU2141965C1 (cg-RX-API-DMAC10.html)
SA (1) SA97170757A (cg-RX-API-DMAC10.html)
SI (1) SI0676409T1 (cg-RX-API-DMAC10.html)
SK (1) SK284079B6 (cg-RX-API-DMAC10.html)
SV (1) SV1995000018A (cg-RX-API-DMAC10.html)
TN (1) TNSN95026A1 (cg-RX-API-DMAC10.html)
TW (1) TW316908B (cg-RX-API-DMAC10.html)
UA (1) UA44705C2 (cg-RX-API-DMAC10.html)
WO (1) WO1995027720A1 (cg-RX-API-DMAC10.html)
YU (1) YU49221B (cg-RX-API-DMAC10.html)
ZA (1) ZA952059B (cg-RX-API-DMAC10.html)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732023B1 (fr) * 1995-03-22 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2745289B1 (fr) * 1996-02-28 1998-05-29 Roussel Uclaf Nouveaux derives de l'acide 1(2h) quinoleine carboxylique, leur procede de preparation et leur application a la synthese de produits doues de proprietes antibiotiques
KR20000011071A (ko) * 1996-05-07 2000-02-25 스티븐 에프. 웨인스톡 3-데스클라디노스-2,3-안하이드로에리트로마이신 유도체
US5750510A (en) * 1997-04-04 1998-05-12 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
FR2748746B1 (fr) * 1996-05-14 1998-08-14 Hoechst Marion Roussel Inc Nouveau procede d'isomerisation du radical methyle en 10 de derives de l'erythromycine
FR2751656B1 (fr) * 1996-07-24 1998-10-16 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
WO1998009978A1 (en) * 1996-09-04 1998-03-12 Abbott Laboratories 6-o-substituted ketolides having antibacterial activity
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2760017B1 (fr) * 1997-02-27 1999-04-30 Hoechst Marion Roussel Inc Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
US6165986A (en) * 1997-03-10 2000-12-26 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
US6140479A (en) * 1997-03-24 2000-10-31 Taisho Pharmaceuticals Co., Ltd. Erythromycin a derivatives
US6162794A (en) * 1997-05-09 2000-12-19 Pfizer Inc. Erythromycin derivatives
US5922683A (en) * 1997-05-29 1999-07-13 Abbott Laboratories Multicyclic erythromycin derivatives
KR20010013660A (ko) * 1997-06-11 2001-02-26 실버스타인 아써 에이. 9-옥심 에리트로마이신 유도체
FR2771008B1 (fr) * 1997-11-17 2000-04-28 Hoechst Marion Roussel Inc Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
ATE298761T1 (de) 1998-09-22 2005-07-15 Pfizer Prod Inc Carbamat- und carbazatketolidantibiotika
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
ATE344269T1 (de) 1998-12-10 2006-11-15 Pfizer Prod Inc Carbamat und carbazat ketolid antibiotika
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
EP1749832A3 (en) * 1998-12-10 2008-03-26 Pfizer Products Incorporated Carbamate and carbazate ketolide antibiotics
FR2789392B1 (fr) * 1999-02-04 2001-10-05 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity
DE60030847T2 (de) * 1999-04-16 2007-04-19 Kosan Biosciences, Inc., Hayward Antiinfektiöse makrolidderivate
JP2002542197A (ja) 1999-04-16 2002-12-10 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド ケトライド抗菌剤
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
CN1351608A (zh) * 1999-05-24 2002-05-29 辉瑞产品公司 13-甲基红霉素衍生物
EP1404693A2 (en) 2001-07-03 2004-04-07 Chiron Corporation C12 modified erythromycin macrolides and ketolides having antibacterial activity
AU2003280305B2 (en) 2002-07-01 2008-05-01 Arkion Life Sciences Llc Process and materials for production of glucosamine and N-acetylglucosamine
WO2004080391A2 (en) * 2003-03-10 2004-09-23 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
JP2006524706A (ja) * 2003-04-25 2006-11-02 カイロン コーポレイション 新規なケトライド誘導体
CA2523134A1 (en) * 2003-04-25 2004-11-11 Chiron Corporation Pyridyl substituted ketolide antibiotics
US9453042B2 (en) * 2007-10-25 2016-09-27 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
CN102245195B (zh) 2008-10-24 2016-01-13 森普拉制药公司 使用含三唑的大环内酯的生物防御
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
CN102724874B (zh) 2009-09-10 2018-06-01 森普拉制药公司 治疗疟疾、结核病和mac疾病的方法
PL2550286T3 (pl) 2010-03-22 2016-07-29 Cempra Pharmaceuticals Inc Krystaliczne postaci makrolidu i ich zastosowanie
CA2799937A1 (en) 2010-05-20 2011-11-24 Cempra Pharmaceuticals, Inc. Processes for preparing macrolides and ketolides and intermediates therefor
JP6042334B2 (ja) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ,インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド
SG11201405895UA (en) 2012-03-27 2014-10-30 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
RU2015138796A (ru) 2013-03-14 2017-04-19 Семпра Фармасьютикалс, Инк. Способы и составы для лечения респираторных заболеваний
HK1218864A1 (zh) 2013-03-15 2017-03-17 森普拉制药公司 用於制备大环内酯抗菌剂的收敛方法
EP4095146A1 (en) 2013-04-04 2022-11-30 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
CA2963815A1 (en) * 2014-10-08 2016-04-14 President And Fellows Of Harvard College 14-membered ketolides and methods of their preparation and use
HK1250371A1 (zh) 2015-03-25 2018-12-14 President And Fellows Of Harvard College 具有修饰的脱氧糖胺糖的大环内酯及其用途
MD1222Z (ro) * 2017-05-31 2018-08-31 ИНСТИТУТ ЭЛЕКТРОННОЙ ИНЖЕНЕРИИ И НАНОТЕХНОЛОГИЙ "D. Ghitu" АНМ Procedeu de tratare a materialului săditor al florilor înainte de plantare
JP7199722B2 (ja) 2019-12-25 2023-01-06 旭精工株式会社 硬貨搬送振分機構及びそれを備えた硬貨識別搬送装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868414A (en) * 1973-01-22 1975-02-25 Merck & Co Inc Tetrahydrofluorene carboxylic acids and related compounds
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
DE2842759A1 (de) * 1978-09-30 1980-04-10 Merck Patent Gmbh Basische aether, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives
FR2692579B1 (fr) * 1992-06-19 1995-06-02 Roussel Uclaf Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments.
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
FR2702480B1 (fr) * 1993-03-09 1995-04-28 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
EE9500080A (et) 1996-12-16
AU684939B2 (en) 1998-01-08
HU215396B (hu) 1998-12-28
PL311871A1 (en) 1996-03-18
UA44705C2 (uk) 2002-03-15
IS4309A (is) 1995-11-17
NO308361B1 (no) 2000-09-04
JP3000023B2 (ja) 2000-01-17
WO1995027720A1 (fr) 1995-10-19
CZ322395A3 (en) 1996-08-14
HRP950217A2 (en) 1997-08-31
IL112954A (en) 2000-07-16
IL112954A0 (en) 1995-06-29
FI955913A0 (fi) 1995-12-08
ES2189820T3 (es) 2003-07-16
RO115634B1 (ro) 2000-04-28
FI955913A7 (fi) 1995-12-08
SK154695A3 (en) 1996-10-02
PT676409E (pt) 2003-08-29
DE69529934D1 (de) 2003-04-24
MA23501A1 (fr) 1995-12-31
TW316908B (cg-RX-API-DMAC10.html) 1997-10-01
AP9500743A0 (en) 1995-07-31
US5656607A (en) 1997-08-12
MY114672A (en) 2002-12-31
EP0676409A1 (fr) 1995-10-11
BG100150A (bg) 1996-06-28
ATE234853T1 (de) 2003-04-15
ZA952059B (en) 1996-03-13
NO954942D0 (no) 1995-12-06
MD663F1 (ro) 1997-01-31
SI0676409T1 (en) 2003-06-30
HRP950217B1 (en) 2004-06-30
SK284079B6 (sk) 2004-09-08
GB2288174A (en) 1995-10-11
GEP19991836B (en) 1999-11-05
LV11182A (lv) 1996-04-20
AU2310795A (en) 1995-10-30
PL180837B1 (pl) 2001-04-30
YU49221B (sh) 2004-11-25
DK0676409T3 (da) 2003-06-23
FR2718450A1 (fr) 1995-10-13
BG61916B1 (bg) 1998-09-30
EP0676409B1 (fr) 2003-03-19
JO1850B1 (en) 1995-12-27
AP587A (en) 1997-04-29
KR100317148B1 (ko) 2002-06-22
CA2164638C (fr) 2003-12-30
FI111264B (fi) 2003-06-30
NO954942L (no) 1996-02-07
CN1126997A (zh) 1996-07-17
CO4370097A1 (es) 1996-10-07
DZ1869A1 (fr) 2002-02-17
CA2164638A1 (fr) 1995-10-19
IS1865B (is) 2003-05-02
HUT73772A (en) 1996-09-30
OA10200A (fr) 1996-12-18
TNSN95026A1 (fr) 1996-02-06
EE04498B1 (et) 2005-06-15
HU9503505D0 (en) 1996-02-28
SA97170757A (ar) 2005-12-03
YU21695A (sh) 1997-12-05
MD663G2 (ro) 1997-07-31
US5760233A (en) 1998-06-02
CN1059445C (zh) 2000-12-13
FR2718450B1 (fr) 1997-01-10
LV11182B (en) 1997-04-20
DE69529934T2 (de) 2003-09-04
RU2141965C1 (ru) 1999-11-27
JPH07278177A (ja) 1995-10-24
GB9506856D0 (en) 1995-05-24
PE2896A1 (es) 1996-02-12
CZ296005B6 (cs) 2005-12-14
SV1995000018A (es) 1997-10-24
NZ284498A (en) 1997-07-27

Similar Documents

Publication Publication Date Title
BR9506147A (pt) Novos derivados de eritromicina seu processo de preparação e sua aplicação como medicamentos
PT885234E (pt) Novos derivados da eritromicina, seu processo de preparacao e sua aplicacao como medicamentos
FI964395L (fi) Uudet erytromysiinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä
EE03231B1 (et) Tetratsüklilised derivaadid, nende valmistamismeetod ja kasutamine
EE03482B1 (et) Kinasoliiniderivaadid, nende valmistamismeetod ja kasutamine
BR9611198A (pt) Composto processo de preparação do mesmo e composição farmacêutica
FI955235A7 (fi) Oksatsolidiinionijohdannaiset, niiden valmistus ja käyttö
EE03338B1 (et) Tromboosivastane ravim, selle valmistamise protsess ja kasutamine
FR13C0008I2 (fr) Derives de phosphonocephem, leur procede de preparation et leur utilisation
FI953898A0 (fi) Glysiiniamidijohdannaisia, menetelmiä niiden valmistamiseksi ja niitä sisältäviä lääkeaineita
PT1016669E (pt) Novos derivados da eritromicina, seu processo de preparacao e a sua aplicacao como medicamentos
BR8804191A (pt) Derivados de avermectina,processo para sua preparacao,composicoes praguicidas e aplicacao
PT1004592E (pt) Novos derivados da eritromicina seu processo de preparacao e sua aplicacao como medicamentos
BR9805297B1 (pt) derivados de 1,3,8-triazaspiro[4,5]decan-4-ona, seu referido processo de preparação e medicamento.
PT1015421E (pt) Novos derivados de fenilamidina processo para a sua preparacao e sua utilizacao como medicamentos
BR9204547A (pt) Hidroxipiridoncarboxamidas,processo de sua preparacao e aplicacao
BR9602337A (pt) Composto processo para sua preparação usos do mesmo processo para tratamento de arritmias e medicamento
FI954946L (fi) Kinoksaliinit, menetelmä niiden valmistamiseksi ja niiden käyttö
BR9710537A (pt) Novos derivados da eritromicina seu processo de preparo e sua aplica-Æo como medicamentos
BR9600778A (pt) Benzenossulfoniluréia e - tiouréla substituida processo para sua preparação seu uso e medicamento
FI943642L (fi) Sulfatoidut polysakkaridit, menetelmä niiden valmistamiseksi, farmaseuttinen valmistus ja käyttö
FI941094L (fi) Uudet erytromysiinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä
PT1036090E (pt) Derivados da equinocandina, seu processo de preparacao e sua aplicacao como antifungicos
PT946579E (pt) Novos derivados da eritromicina seu processo de preparacao e sua aplicacao como medicamentos
PT1053224E (pt) Bifenilsulfonilcianamida, processo para a sua preparacao e sua utilizacao como medicamento

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
HJEG Technical examination (opinion): technical examination (opinion) related to article 229 of industrial property law
FF Decision: intention to grant
FG9A Patent or certificate of addition granted
B25A Requested transfer of rights approved

Owner name: AVENTIS PHARMA S.A. (FR)

Free format text: TRANSFERIDO POR FUSAO DE: HOECHST MARION ROUSSEL

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 06/04/2015